In conclusion, development of ALPS model integrating five lncRNAs (MAPT‐AS1, LINC01871, AL122010.1, AC090912.1, AC061992.1), derived from machine learning based screening, could well predict the survival of breast cancer patients. This evidence concerns the gene MAPT and breast cancer.